Brief: Antengene Announces NMPA Approval Of IND Application For ATG-010 In Combination With R-GDP
25/01/2021 01:16
Jan 25 (Reuters) - Antengene Corp Ltd 6996.HK :
* GOT APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION BY
NMPA FOR
ATG-010 (SELINEXOR) IN COMBINATION WITH R-GDP (SR-GDP)
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0125/2021012500063.pdf
Further company coverage: 6996.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106